Cleared Traditional

K181660 - Acapella Choice Blue Vibratory PEP Device

K181660 is the FDA 510(k) clearance for Acapella Choice Blue Vibratory PEP Device by Smiths Medical. It is a Class 2 Anesthesiology device (product code BWF) cleared through the Traditional 510(k) pathway after a 486-day FDA review.

K181660 · Smiths Medical · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
486d
Days
Class 2
Risk

K181660 is an FDA 510(k) clearance for the Acapella Choice Blue Vibratory PEP Device. Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by Smiths Medical (Plymouth, US). The FDA issued a Cleared decision on October 24, 2019 after a review of 486 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Smiths Medical devices

Submission Details

510(k) Number K181660 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2018
Decision Date October 24, 2019
Days to Decision 486 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
346d slower than avg
Panel avg: 140d · This submission: 486d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Mrc-X, LLC
Dawn Norman

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 28
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K181660.
Hudson RCI Triflo II Incentive Deep Breathing Exerciser
K220565 · Medline Industries, Inc. · Oct 2022
Pulsehaler
K203378 · Respinova, Ltd. · Mar 2021
D R Burton OxyPAP
K192000 · D R Burton Healthcare, LLC · Feb 2020
Combined Aerobika OPEP and VersaPAP device
K183108 · Trudell Medical International · Aug 2019
Hudson RCI Voldyne Volumetric Exerciser
K182847 · Teleflexmedical, Inc. · Jul 2019
VersaPAP Positive Airway Pressure (PAP) Device
K173918 · Trudell Medical International · Aug 2018